Literature DB >> 1166898

The use of bethanechol chloride with tricyclic antidepressants.

H C Everett.   

Abstract

The author describes the use of bethanechol chloride to relieve side effects, including salivary inactivation, constipation, and bladder inhibition, which result from the anticholinergic action of tricyclic antidepressants. He suggests that the use of cholinergic medication during antidepressant therapy may extend the use of the tricyclics to patients who find anticholinergic side effects especially troublesome.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1166898     DOI: 10.1176/ajp.132.11.1202

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

1.  Antidepressants in the general hospital.

Authors:  A J Gelenberg
Journal:  Can Med Assoc J       Date:  1979-06-09       Impact factor: 8.262

Review 2.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738

3.  Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.

Authors:  Sara Chowdhury; Songyan Wang; Judit Dunai; Rachel Kilpatrick; Lauren Z Oestricker; Michael J Wallendorf; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

4.  Influence of bethanechol on salivary parameters in irradiated patients.

Authors:  C Cotomacio; L Campos; A Simões; G Jaguar; E-M Crosato; F Abreu-Alves
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.